Clinical Trial

Oral Iron Supplementation for Patients With Chronic Kidney Disease

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The hypothesis of this research is that oral iron prescribed in a single dose in alternate day could mitigate the side effects with regard to intestinal microbiota, inflammation, oxidative stress and improve the hematological profile when compared to daily oral iron prescription
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-09-15; most recent amendment 2025-04-01.
Trial Details
NCT Number NCT05544513
Lead Sponsor Universidade Federal Fluminense
Conditions Chronic Renal Disease, Iron-Deficiency Anemia, Anemia of Chronic Kidney Disease, Dysbiosis
Enrollment 6 participants
Start Date 2022-08-01
Primary Completion 2026-12-29 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-03